vs
Side-by-side financial comparison of PTC THERAPEUTICS, INC. (PTCT) and ZIPRECRUITER, INC. (ZIP). Click either name above to swap in a different company.
PTC THERAPEUTICS, INC. is the larger business by last-quarter revenue ($164.7M vs $111.7M, roughly 1.5× ZIPRECRUITER, INC.). ZIPRECRUITER, INC. runs the higher net margin — -0.7% vs -82.0%, a 81.2% gap on every dollar of revenue. On growth, ZIPRECRUITER, INC. posted the faster year-over-year revenue change (0.6% vs -22.7%). ZIPRECRUITER, INC. produced more free cash flow last quarter ($7.6M vs $-36.6M). Over the past eight quarters, ZIPRECRUITER, INC.'s revenue compounded faster (-4.4% CAGR vs -11.5%).
PTC Therapeutics, Inc. is a US pharmaceutical company focused on the development of orally administered small molecule drugs and gene therapy which regulate gene expression by targeting post-transcriptional control (PTC) mechanisms in orphan diseases.
ZipRecruiter, Inc. is an American employment marketplace for job seekers and employers.
PTCT vs ZIP — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $164.7M | $111.7M |
| Net Profit | $-135.0M | $-835.0K |
| Gross Margin | — | 89.1% |
| Operating Margin | -43.3% | 3.6% |
| Net Margin | -82.0% | -0.7% |
| Revenue YoY | -22.7% | 0.6% |
| Net Profit YoY | -104.8% | 92.3% |
| EPS (diluted) | $-1.63 | $-0.03 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $164.7M | $111.7M | ||
| Q3 25 | $211.0M | $115.0M | ||
| Q2 25 | $178.9M | $112.2M | ||
| Q1 25 | $1.2B | $110.1M | ||
| Q4 24 | $213.2M | $111.0M | ||
| Q3 24 | $196.8M | $117.1M | ||
| Q2 24 | $186.7M | $123.7M | ||
| Q1 24 | $210.1M | $122.2M |
| Q4 25 | $-135.0M | $-835.0K | ||
| Q3 25 | $15.9M | $-9.8M | ||
| Q2 25 | $-64.8M | $-9.5M | ||
| Q1 25 | $866.6M | $-12.8M | ||
| Q4 24 | $-65.9M | $-10.8M | ||
| Q3 24 | $-106.7M | $-2.6M | ||
| Q2 24 | $-99.2M | $7.0M | ||
| Q1 24 | $-91.6M | $-6.5M |
| Q4 25 | — | 89.1% | ||
| Q3 25 | — | 89.1% | ||
| Q2 25 | — | 89.3% | ||
| Q1 25 | — | 89.4% | ||
| Q4 24 | — | 89.6% | ||
| Q3 24 | — | 89.4% | ||
| Q2 24 | — | 89.5% | ||
| Q1 24 | — | 89.1% |
| Q4 25 | -43.3% | 3.6% | ||
| Q3 25 | 1.4% | -4.4% | ||
| Q2 25 | -19.5% | -5.9% | ||
| Q1 25 | 82.5% | -10.6% | ||
| Q4 24 | -76.2% | -3.6% | ||
| Q3 24 | -27.7% | -2.8% | ||
| Q2 24 | -21.5% | 7.6% | ||
| Q1 24 | -21.6% | -0.7% |
| Q4 25 | -82.0% | -0.7% | ||
| Q3 25 | 7.5% | -8.5% | ||
| Q2 25 | -36.3% | -8.5% | ||
| Q1 25 | 73.7% | -11.7% | ||
| Q4 24 | -30.9% | -9.7% | ||
| Q3 24 | -54.2% | -2.2% | ||
| Q2 24 | -53.1% | 5.7% | ||
| Q1 24 | -43.6% | -5.3% |
| Q4 25 | $-1.63 | $-0.03 | ||
| Q3 25 | $0.20 | $-0.11 | ||
| Q2 25 | $-0.83 | $-0.10 | ||
| Q1 25 | $10.04 | $-0.13 | ||
| Q4 24 | $-0.85 | $-0.10 | ||
| Q3 24 | $-1.39 | $-0.03 | ||
| Q2 24 | $-1.29 | $0.07 | ||
| Q1 24 | $-1.20 | $-0.07 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $1.9B | $188.0M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $-205.3M | $-77.2M |
| Total Assets | $2.9B | $569.7M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $1.9B | $188.0M | ||
| Q3 25 | $1.7B | $211.8M | ||
| Q2 25 | $2.0B | $203.5M | ||
| Q1 25 | $2.0B | $221.1M | ||
| Q4 24 | $1.1B | $218.4M | ||
| Q3 24 | $1.0B | $225.6M | ||
| Q2 24 | $1.1B | $271.7M | ||
| Q1 24 | $884.8M | $282.5M |
| Q4 25 | $-205.3M | $-77.2M | ||
| Q3 25 | $-155.8M | $-76.1M | ||
| Q2 25 | $-206.5M | $-65.9M | ||
| Q1 25 | $-185.8M | $-11.3M | ||
| Q4 24 | $-1.1B | $13.4M | ||
| Q3 24 | $-1.1B | $13.6M | ||
| Q2 24 | $-980.2M | $24.4M | ||
| Q1 24 | $-893.9M | $12.7M |
| Q4 25 | $2.9B | $569.7M | ||
| Q3 25 | $2.6B | $573.6M | ||
| Q2 25 | $2.6B | $592.4M | ||
| Q1 25 | $2.7B | $629.4M | ||
| Q4 24 | $1.7B | $664.1M | ||
| Q3 24 | $1.8B | $652.0M | ||
| Q2 24 | $1.9B | $665.3M | ||
| Q1 24 | $1.8B | $662.4M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-34.3M | $7.7M |
| Free Cash FlowOCF − Capex | $-36.6M | $7.6M |
| FCF MarginFCF / Revenue | -22.3% | 6.8% |
| Capex IntensityCapex / Revenue | 1.4% | 0.1% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $702.3M | $9.9M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-34.3M | $7.7M | ||
| Q3 25 | $-66.3M | $2.6M | ||
| Q2 25 | $-58.3M | $10.5M | ||
| Q1 25 | $870.1M | $-9.9M | ||
| Q4 24 | $-30.0M | $12.5M | ||
| Q3 24 | $-77.0M | $9.3M | ||
| Q2 24 | $-71.5M | $21.9M | ||
| Q1 24 | $70.8M | $2.0M |
| Q4 25 | $-36.6M | $7.6M | ||
| Q3 25 | $-69.7M | $2.2M | ||
| Q2 25 | $-59.6M | $10.2M | ||
| Q1 25 | $868.4M | $-10.2M | ||
| Q4 24 | $-33.8M | $12.0M | ||
| Q3 24 | $-77.5M | $9.2M | ||
| Q2 24 | $-78.8M | $21.7M | ||
| Q1 24 | $61.2M | $1.9M |
| Q4 25 | -22.3% | 6.8% | ||
| Q3 25 | -33.1% | 1.9% | ||
| Q2 25 | -33.3% | 9.1% | ||
| Q1 25 | 73.8% | -9.3% | ||
| Q4 24 | -15.8% | 10.8% | ||
| Q3 24 | -39.4% | 7.8% | ||
| Q2 24 | -42.2% | 17.6% | ||
| Q1 24 | 29.1% | 1.6% |
| Q4 25 | 1.4% | 0.1% | ||
| Q3 25 | 1.6% | 0.3% | ||
| Q2 25 | 0.7% | 0.3% | ||
| Q1 25 | 0.1% | 0.3% | ||
| Q4 24 | 1.8% | 0.4% | ||
| Q3 24 | 0.3% | 0.2% | ||
| Q2 24 | 4.0% | 0.1% | ||
| Q1 24 | 4.6% | 0.1% |
| Q4 25 | — | — | ||
| Q3 25 | -4.17× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 1.00× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 3.12× | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
PTCT
Segment breakdown not available.
ZIP
| License | $84.3M | 75% |
| Services | $27.4M | 25% |
